Suppr超能文献

慢性丙型肝炎的治疗

Therapy for chronic hepatitis C.

作者信息

Davis G L, Lau J Y, Lim H L

机构信息

Section of Hepatobiliary Diseases, University of Florida College of Medicine, Gainesville.

出版信息

Gastroenterol Clin North Am. 1994 Sep;23(3):603-13.

PMID:7527375
Abstract

Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients. Few patients with chronic hepatitis C derive long-term improvement from a single 6-month course of interferon therapy. Most initial responders relapse and require long-term interferon treatment to suppress the virus. Obviously, the initial goals and expectations for interferon therapy require rethinking. Therapy should not be undertaken by physician or patient with the idea that therapy will be limited to 6 months. The most appropriate goal of therapy now appears to be the long-term control of the biochemical, virologic, and histologic activity of the disease. Unfortunately, the most effective therapeutic regimen for achieving this goal is not yet known and will require continued clinical research.

摘要

丙型肝炎是20世纪70年代和80年代的隐匿性流行病。目前,α干扰素是唯一有效的治疗方法。由于晚期疾病通常需要数年甚至数十年才会发展,而且并非所有患者都会出现,因此对干扰素治疗的热情必须有所降温。很少有慢性丙型肝炎患者能从单次6个月疗程的干扰素治疗中获得长期改善。大多数初始应答者会复发,需要长期使用干扰素治疗来抑制病毒。显然,对干扰素治疗的最初目标和期望需要重新思考。医生或患者在进行治疗时,不应认为治疗将仅限于6个月。现在看来,最恰当的治疗目标似乎是长期控制该疾病的生化、病毒学和组织学活性。不幸的是,实现这一目标的最有效治疗方案尚不清楚,还需要继续进行临床研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验